Journal article

Guideline for allergen immunotherapy in IgE-mediated allergic diseases


Authors listPfaar, O.; Ankermann, T.; Augustin, M.; Bubel, P.; Boeing, S.; Brehler, R.; Eng, P. A.; Fischer, P. J.; Gerstlauer, M.; Hamelmann, E.; Jakob, T.; Kleine-Tebbe, J.; Kopp, M., V; Lau, S.; Muelleneisen, N.; Mueller, C.; Nemat, K.; Pfuetzner, W.; Saloga, J.; Stroemer, K.; Schmid-Grendelmeier, P.; Schuster, A.; Sturm, G. J.; Taube, C.; Szepfalusi, Z.; Vogelberg, C.; Wagenmann, M.; Wehrmann, W.; Werfel, T.; Woehrl, S.; Worm, M.; Wedi, B.; Kau, S.; Mahler, V; Schwalfenberg, A.

Publication year2022

Pages643-701

JournalAllergologie

Volume number45

Issue number9

ISSN0344-5062

DOI Linkhttps://doi.org/10.5414/ALX02331E

PublisherDustri-Verlag



Citation Styles

Harvard Citation stylePfaar, O., Ankermann, T., Augustin, M., Bubel, P., Boeing, S., Brehler, R., et al. (2022) Guideline for allergen immunotherapy in IgE-mediated allergic diseases, Allergologie, 45(9), pp. 643-701. https://doi.org/10.5414/ALX02331E

APA Citation stylePfaar, O., Ankermann, T., Augustin, M., Bubel, P., Boeing, S., Brehler, R., Eng, P., Fischer, P., Gerstlauer, M., Hamelmann, E., Jakob, T., Kleine-Tebbe, J., Kopp, M., Lau, S., Muelleneisen, N., Mueller, C., Nemat, K., Pfuetzner, W., Saloga, J., ...Schwalfenberg, A. (2022). Guideline for allergen immunotherapy in IgE-mediated allergic diseases. Allergologie. 45(9), 643-701. https://doi.org/10.5414/ALX02331E



Keywords


ADVERSE SYSTEMIC REACTIONSDOUBLE-BLINDGRASS-POLLEN IMMUNOTHERAPYHOUSE-DUST-MITEPERSISTENT SUBCUTANEOUS NODULESQUALITY-OF-LIFERANDOMIZED CONTROLLED-TRIALSHORT-TERM IMMUNOTHERAPYSUBLINGUAL IMMUNOTHERAPY

Last updated on 2025-02-04 at 00:01